tiprankstipranks
Jubilant Ingrevia Ltd. (IN:JUBLINGREA)
:JUBLINGREA
India Market
Want to see IN:JUBLINGREA full AI Analyst Report?

Jubilant Ingrevia Ltd. (JUBLINGREA) Price & Analysis

3 Followers

JUBLINGREA Stock Chart & Stats

₹726.00
-₹47.65(-5.70%)
At close: 4:00 PM EST
₹726.00
-₹47.65(-5.70%)

Bulls Say, Bears Say

Bulls Say
Revenue StabilizationThe return to revenue growth indicates demand has stabilized after a weaker period. Continued expansion across specialty chemicals and ingredients could support a more durable recovery in volumes and product mix.
Manageable LeverageModerate leverage limits near-term balance-sheet strain and preserves some capacity to fund operations or growth. Steadily growing equity also provides a resilience buffer against cyclical chemical-market conditions.
Diversified End MarketsExposure to several life-science and industrial applications reduces reliance on one customer group or end market. This broad portfolio can support recurring B2B demand and improve resilience through sector-specific cycles.
Bears Say
Weak Cash ConversionPersistent conversion of earnings into cash below one times raises questions about working capital, receivables, or earnings quality. Volatile free cash flow can constrain reinvestment, debt reduction, and shareholder distributions.
Lower And Volatile MarginsMargins remain positive but below prior-cycle levels, while gross-margin volatility signals uneven pricing and input-cost absorption. Sustained pressure could limit earnings growth even if revenue continues to expand.
Declining Capital EfficiencyAlthough leverage is still manageable, its increase reduces financial flexibility relative to earlier years. Falling ROE indicates weaker use of shareholder capital, potentially limiting returns unless profitability and asset productivity improve.

Jubilant Ingrevia Ltd. News

JUBLINGREA FAQ

What was Jubilant Ingrevia Ltd.’s price range in the past 12 months?
Jubilant Ingrevia Ltd. lowest stock price was ₹535.30 and its highest was ₹794.95 in the past 12 months.
    What is Jubilant Ingrevia Ltd.’s market cap?
    Jubilant Ingrevia Ltd.’s market cap is ₹109.79B.
      When is Jubilant Ingrevia Ltd.’s upcoming earnings report date?
      Jubilant Ingrevia Ltd.’s upcoming earnings report date is Oct 21, 2026 which is in 53 days.
        How were Jubilant Ingrevia Ltd.’s earnings last quarter?
        Jubilant Ingrevia Ltd. released its earnings results on Jul 22, 2026. The company reported ₹6.7 earnings per share for the quarter, the consensus estimate of ₹6.7 by ₹0.
          Is Jubilant Ingrevia Ltd. overvalued?
          According to Wall Street analysts Jubilant Ingrevia Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Jubilant Ingrevia Ltd. pay dividends?
            Jubilant Ingrevia Ltd. pays a Semiannually dividend of ₹2.5 which represents an annual dividend yield of 0.73%. See more information on Jubilant Ingrevia Ltd. dividends here
              What is Jubilant Ingrevia Ltd.’s EPS estimate?
              Jubilant Ingrevia Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Jubilant Ingrevia Ltd. have?
              Jubilant Ingrevia Ltd. has 159,281,140 shares outstanding.
                What happened to Jubilant Ingrevia Ltd.’s price movement after its last earnings report?
                Jubilant Ingrevia Ltd. reported an EPS of ₹6.7 in its last earnings report, expectations of ₹6.7. Following the earnings report the stock price went down -2.813%.
                  Which hedge fund is a major shareholder of Jubilant Ingrevia Ltd.?
                  Currently, no hedge funds are holding shares in IN:JUBLINGREA
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Jubilant Ingrevia Ltd.

                    Jubilant Ingrevia Limited, established in 2019 and based in Noida, India, is a global supplier of life science products and comprehensive solutions. The company's operations are divided into three core divisions: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment delivers a variety of specialized ingredients, fine chemicals, and crop protection agents, in addition to offering custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division focuses on ingredients for both human and animal nutrition and well-being. Meanwhile, the Life Science Chemicals segment provides crucial life science components and a range of specialized ethanol products. Jubilant Ingrevia's extensive portfolio encompasses numerous chemical offerings, including a broad spectrum of pyridine derivatives (such as picolines, cyanopyridines, and various substituted pyridines), essential vitamins like B3 and riboflavin phosphate sodium, and nutritional compounds like premixes and antioxidants. They also produce industrial chemicals like acetic anhydride, ethyl acetate, and various alcohols (absolute alcohol, ethanol), alongside biocompost and gas mixtures. Furthermore, the company supplies a wide array of animal health and nutrition additives, including mineral premixes, stress regulators, amino acids, herbal growth promoters, toxin binders, and enzymes. Beyond its product range, Jubilant Ingrevia offers specialized services in chemical synthesis, covering everything from initial route design and process optimization to scaling up production and commercial manufacturing of intermediates. The company serves a diverse client base across the pharmaceutical, nutrition, agrochemical, consumer goods, and industrial sectors. Originally incorporated as Jubilant LSI Limited, the company adopted its current name, Jubilant Ingrevia Limited, in October 2020.

                    Jubilant Ingrevia Ltd. (JUBLINGREA) Earnings & Revenues

                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Concord Biotech Ltd.
                    Dishman Carbogen Amcis Ltd.
                    Piramal Pharma Limited
                    Syngene International Ltd.
                    OneSource Specialty Pharma Limited
                    Popular Stocks